Found 544 matching trials
Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy PHASE4 The objective of this study is to better understand the influence of insuli...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment PHASE4 This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Show More Location
Multiple Locations
Learn More & Join Trial
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED) N/A Patients receiving a patient assistance program during therapy for Hepatiti...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PHASE2 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C PHASE3 This study is to evaluate the overall efficacy, and safety profile of the t...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C PHASE1 The purpose of this study is to (1) determine the effects of the herbal for...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C PHASE2 This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Show More Learn More & Join Trial
Effect of Boceprevir on HCV-specific T Cell Responses N/A Analysis of HCV-specific T cell responses in patients treated with boceprev...
Show More Location
Unit of Infectious Diseases and Hepatology
Learn More & Join Trial